Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT05041933
Eligibility Criteria:
Inclusion Criteria:
* Subjects aged 18 years or over.
* Eligible for care by one of the four HAH structures in accordance with HAS criteria,
* With relapsed or refractory multiple myeloma (having received at least one previous treatment),
* Whose case has been examined at multidisciplinary team (MDT) meetings at Limoges University Hospital Centre,
* Receiving carfilzomib parenteral chemotherapy outsourced to an HAH setting (all patients receive the entire first cycle of carfilzomib and the 1st day of each of the subsequent cycles in an outpatient clinic).
* Having read the information leaflet concerning the Carfil-HAD study,
* Not objecting to the use of their data in the context of this study.
Exclusion Criteria:
* Inability to understand the protocol or complete the questionnaires.
* Refusing to complete the questionnaires.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05041933
Study Brief:
Protocol Section:
NCT05041933